Vision fighter: Durham gene therapy startup lands $24.5M with clinical trial underway
Atsena Therapeutics – a clinical-stage gene therapy company that’s fighting to reverse and prevent blindness and recently launched a clinical trial for a possible treatment, has landed $24.5 million from investors to carry on the battle.
Read More